BALPHARMA.BOBALPHARMA.BOBSE
Loading
Year-over-year gross profit growth rate
Percentile
P5
Near historical low
vs 5Y Ago
-3.2x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -38.47% |
| Q3 2025 | 5.45% |
| Q2 2025 | 59.79% |
| Q1 2025 | -44.26% |
| Q4 2024 | 1.67% |
| Q3 2024 | 98.95% |
| Q2 2024 | -22.21% |
| Q1 2024 | -35.59% |
| Q4 2023 | -8.70% |
| Q3 2023 | 25.03% |
| Q2 2023 | -16.00% |
| Q1 2023 | 17.69% |
| Q4 2022 | -4.91% |
| Q3 2022 | 15.16% |
| Q2 2022 | 10.52% |
| Q1 2022 | -9.78% |
| Q4 2021 | -7.21% |
| Q3 2021 | 25.56% |
| Q2 2021 | -9.28% |
| Q1 2021 | 5.57% |
| Q4 2020 | 12.02% |
| Q3 2020 | 3.31% |
| Q2 2020 | 30.20% |
| Q1 2020 | -16.16% |
| Q4 2019 | -14.25% |
| Q3 2019 | 2.11% |
| Q2 2019 | -11.92% |
| Q1 2019 | 13.13% |
| Q4 2018 | -21.59% |
| Q3 2018 | 27.54% |
| Q2 2018 | -25.87% |
| Q1 2018 | 18.30% |
| Q4 2017 | 89.92% |
| Q3 2017 | 11.68% |
| Q2 2017 | -62.10% |
| Q1 2017 | 14.15% |
| Q4 2016 | -5.88% |
| Q3 2016 | 32.38% |
| Q2 2016 | -2.02% |
| Q1 2016 | -2.53% |